✓ Translated by DotMD AI Clinical Council Source: Circulation. Cardiovascular quality and outcomes • Randomized Controlled Trial
Verify Primary Source: NIH PubMed PMID #21304095 ↗

Randomized Controlled Trial: Racial differences in incident heart failure during antihypertensive therapy

Original Paper Title: “Racial differences in incident heart failure during antihypertensive therapy”

Elena Rostova (AI Quant) Rigor Score
82 / 100
Sample Size (Participants)
Systematic Review
Evidence Classification
Randomized Controlled Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • Incident HF is substantially more common among black than nonblack hypertensive patients. The increased risk of developing new HF in blacks persists after adjusting for the higher prevalence of HF risk factors in blacks, for treatment effects and in-treatment blood pressure, and for the known predictive value of the ECG strain pattern and.
  • Study Design & Sample: Randomized Controlled Trial published in Circulation. Cardiovascular quality and outcomes (Multi-cohort synthesis).
  • Biostatistical Rigor Score: 82/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Circulation. Cardiovascular quality and outcomes (2011), this randomized controlled trial evaluating human clinical outcomes investigated: Blacks have a higher prevalence of heart failure (HF) than nonblacks, possibly reflecting a greater burden of HF risk factors, including hypertension. Key clinical takeaway: Incident HF is substantially more common among black than nonblack hypertensive patients. The increased risk of developing new HF in blacks persists after adjusting for the higher prevalence of HF risk factors in blacks, for treatment effects and in-treatment blood pressure, and for the known predictive value of the ECG strain pattern and.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Circulation. Cardiovascular quality and outcomes, 2011-03-15; Randomized Controlled Trial; Rigor 82/100): Incident HF is substantially more common among black than nonblack hypertensive patients. The increased risk of developing new HF in blacks persists after adjusting for the higher prevalence of HF risk factors in blacks, for treatment effects and in-treatment blood pressure, and for the known predictive value of the ECG strain pattern and.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: zinc-cold-therapy-zinc-gluconate → Rx: ultra-zinc-cold-therapy-zincum-gluconicum → Rx: north-american-coral-snake-antivenin-equine-coral-snake-micrurus → Rx: pressure-pain-and-mucus-acetaminophen-guaifenesin-phenylephrine-hcl → Condition: thalamic-hemorrhage → Condition: cardiac-injury →
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 21304095: Randomized Controlled Trial: Racial differences in incident heart failure during antihypertensive therapy

3 of 3 Free Questions Remaining